絞り込み

16645

広告

Aspirin inhibits RANKL-induced osteoclast differentiation in dendritic cells by suppressing NF-κB and NFATc1 activation.

著者 Wu L , Luo Z , Liu Y , Jia L , Jiang Y , Du J , Guo L , Bai Y , Liu Y
Stem Cell Res Ther.2019 Dec 05 ; 10(1):375.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (6view , 0users)

Full Text Sources

Miscellaneous

Aspirin has been demonstrated to promote osteoblast-mediated bone formation and inhibit osteoclast (OC)-mediated bone resorption. However, it remains unclear whether aspirin influences other immune cells during bone resorption. Dendritic cells (DCs), the most potent antigen-presenting cells, can also transdifferentiate into active OCs in the presence of receptor activator of nuclear factor-κB ligand (RANKL) and macrophage colony-stimulating factor (M-CSF). The effects of aspirin on DC-derived OCs (DDOCs) were investigated in the current study.
PMID: 31805984 [PubMed - in process]
印刷用ページを開く Endnote用テキストダウンロード